Shares of CEL-SCI climbed after the company reported progress toward the filing of an application for multikine in Saudi Arabia, but pared their gains after it announced a stock offering.

Capricor, which was seeking approval of Deramiocel for the treatment of cardiomyopathy associated with DMD, said the FDA issued a so-called complete response letter, indicating the agency won't ...

Donald Trump launched new tariffs on Wednesday, which included raising duty on Brazilian imports to 50pc from 10pc, effective ...

The FDA on Thursday said it published more than 200 decision letters, known as complete response letters, that it issued in response to applications for approval of drugs or biological products ...

Dow Jones futures dropped Thursday on surprise weekly jobless claims. Nvidia chipmaker TSMC rose on strong sales.

Discover why DJD offers high yield & low expenses but faces risks like low liquidity & sector concentration. Assess its ...

Molina Healthcare is the latest to warn it won't meet Wall Street expectations as it spends more on care in Medicaid, Medicare and Affordable Care Act plans. The bankruptcy of its major customer, ...

Wall Street’s main indices all finished in the red, led by the Dow Jones with 0.94 percent, followed by the Nasdaq with 0.92 ...

DIA ETF tracks the iconic Dow Jones Industrial Average with low expenses but faces drawbacks like limited holdings.

The Dow is fertile ground for those seeking dividend income. It holds several higher-yielding dividend stocks with an ...

The Dow Jones Index continued its strong bull run last week as it neared its all-time high. It has jumped in the last six consecutive days, and is trading at $44,828, a few points below its all-time ...